Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) CEO Henghua Guo's Holdings Dropped 6.1% in Value as a Result of the Recent Pullback

Simply Wall StJan 2 18:01 ET

Huaheng Biology (688639.SH): Plans to inquire about the transfer of 1.34% of its shares.

On December 20, Gelonghui reported that Huaheng Biological (688639.SH) announced it plans to participate in the pre-IPO share transfer inquiry of Huaheng Biological (hereinafter referred to as "this inquiry transfer") by the shareholder Ningbo Ruiheyuan Venture Capital Partnership (Limited Partnership); the seller intends to transfer a total of 3,357,844 shares, accounting for 1.34% of Huaheng Biological's total share capital.

Gelonghui FinanceDec 20, 2024 08:30 ET

Anhui Huaheng Biotechnology to Raise Capital of Two Subsidiaries to Boost Production

MT NewswiresNov 11, 2024 01:47 ET

Anhui Huaheng Biotechnology's (SHSE:688639) Anemic Earnings Might Be Worse Than You Think

Simply Wall StNov 4, 2024 18:07 ET

Huaheng Biology: Report of Anhui Huaheng Biotechnology Co., Ltd. for the third quarter of 2024

SZSIOct 28, 2024 12:00 ET · Announcements

Anhui Huaheng Biotechnology Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 28, 2024 12:00 ET · Announcements